Mrv0541 07171217052D 17 17 0 0 1 0 999 V2000 19.0837 -11.5890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 18.3137 -11.8325 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 17.6396 -11.3309 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 18.0591 -12.5752 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 16.9871 -11.7982 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 17.2410 -12.5752 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 18.3035 -13.3657 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 16.2170 -11.5580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.9768 -13.3624 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 15.5567 -12.0529 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 14.8389 -11.6369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.1203 -12.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.4051 -11.6369 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 12.6866 -12.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.4051 -10.8052 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 11.9723 -11.6369 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 12.6866 -12.8778 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 0 0 0 2 3 1 0 0 0 0 2 4 1 0 0 0 0 3 5 1 0 0 0 0 4 6 1 0 0 0 0 4 7 1 6 0 0 0 5 8 1 1 0 0 0 6 9 1 6 0 0 0 8 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 13 15 1 1 0 0 0 14 16 1 0 0 0 0 14 17 2 0 0 0 0 5 6 1 0 0 0 0 M END > DB02321 > drugbank > N[C@@H](CCSC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O)C(O)=O > InChI=1S/C9H17NO6S/c10-4(8(13)14)1-2-17-3-5-6(11)7(12)9(15)16-5/h4-7,9,11-12,15H,1-3,10H2,(H,13,14)/t4-,5+,6+,7+,9+/m0/s1 > IQFWYNFDWRYSRA-OEQWSMLSSA-N > C9H17NO6S > 267.299 > 267.077657971 > 7 > 34 > -0.00322860152345672 > 26.332277208852396 > 1 > 5 > 0 > 0 > (2S)-2-amino-4-({[(2S,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid > -2.58 > -4.233186655917743 > -0.81 > 0 > 0 > 1 > 0 > 11.31516377364693 > 1.8022463307785992 > 9.495582400043908 > 133.24 > 59.4888 > 6 > 1 > 4.10e+01 g/l > biotin > 0 > DB02321 > EXPT02779 > experimental > 5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol $$$$